Ortivus AB (publ)

Stockholm Stock Exchange ORTI-B.ST

Ortivus AB (publ) Return on Equity (ROE) for the year ending December 31, 2023: -105.43%

Ortivus AB (publ) Return on Equity (ROE) is -105.43% for the year ending December 31, 2023, a -734.08% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Ortivus AB (publ) Return on Equity (ROE) for the year ending December 31, 2022 was 16.63%, a -46.85% change year over year.
  • Ortivus AB (publ) Return on Equity (ROE) for the year ending December 31, 2021 was 31.28%, a -45.68% change year over year.
  • Ortivus AB (publ) Return on Equity (ROE) for the year ending December 31, 2020 was 57.59%, a 130.41% change year over year.
  • Ortivus AB (publ) Return on Equity (ROE) for the year ending December 31, 2019 was -189.40%, a 69.15% change year over year.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
SV Wall Street
Stockholm Stock Exchange: ORTI-B.ST

Ortivus AB (publ)

CEO Mr. Gustaf Nordenhok
IPO Date Jan. 3, 2000
Location Sweden
Headquarters Box 713
Employees 41
Sector Healthcare
Industries
Telehealth Augmented Reality (AR) Biotechnology Hardware & Electronics Internet of Things (IoT) Medical Instruments Mobile Apps Telecommunications & Networking
Description

Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient's vital parameters, such as ECG, blood pressure, and SpO2; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden.

Similar companies

MOB.ST

Moberg Pharma AB (publ)

USD 0.85

-1.32%

StockViz Staff

February 4, 2025

Any question? Send us an email